Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity

Journal of Virology

Volumn 72, Issue 11, 1998, Pages 9329-9336

  Paquette, Jean Sébastien ^b   Fortin, Jean François ^b   Blanchard, Luc ^b   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

EID: 0031657711     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.11.9329-9336.1998     Document Type: Article

References (70)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
2. Arthur, L. O., J. W. J. Bess, R. C. Sowder II, R. E. Benveniste, D. L. Mann, J.-C. Cherman, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implication for pathogenesis and vaccines. Science 258:1935-1938.
3. Benkirane, M., D. Blanc-Zouaoui, M. Hirn, and C. Devaux. 1994. Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells. J. Virol. 68:6332-6339.
4. Berger, E. A. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11:S3-S16.
5. Bess, J. W., P. J. Powell, H. J. Issaq, L. J. Schumack, M. K. Grimes, L. E. Henderson, and L. O. Arthur. 1992. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1, and other retroviruses. J. Virol. 66:840-847.
6. Bess, J. W. J., R. J. Gorelick, W. J. Bosche, L. E. Henderson, and L. O. Arthur. 1997. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 230:134-144.
7. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 15:6580-6584.
8. Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-427.
9. Buttke, T. M., J. A. McCubrey, and T. C. Owen. 1993. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods 157:233-240.
10. Cantin, R., J.-F. Fortin, G. Lamontagne, and M. Tremblay. 1997. The acquisition of host major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 90:1091-1100.
11. Cantin, R., J.-F. Fortin, G. Lamontagne, and M. Tremblay. 1997. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 71:1922-1930.
12. Cantin, R., J.-F. Fortin, and M. Tremblay. 1996. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology 218:372-381.
13. Capobianchi, M. R., S. Fais, C. Castilletti, M. Gentile, F. Ameglio, and F. Dianzani. 1994. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J. Infect. Dis. 169:886-889.
14. Caputo, A., J. G. Sodroski, and W. A. Haseltine. 1990. Constitutive expression of HIV-1 Tat protein in human Jurkat T cells using a BK virus vector. J. Acquired Immune Defic. Syndr. 3:372-379.
15. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101.
16. Castilletti, C., M. R. Capobianchi, S. Fais, I. Abbate, B. Ficociello, F. Ameglio, P. C. Fei, S. M. Santini, and F. Dianzani. 1995. HIV type 1 grown on interferon γ-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res. Hum. Retroviruses 11:547-553.
17. Chen, B. K., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by super-infection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68:654-660.
18. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
19. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. L. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
20. Chrystie, I. L., and J. D. Almeida. 1988. Further studies of HIV morphology by negative staining. AIDS 2:459-464.
21. Dalgleish, A. G., P. C. L. Beverly, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
22. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
23. Diamond, M. S., and T. A. Springer. 1994. The dynamic regulation of integrin adhesiveness. Curr. Biol. 4:506-517.
24. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
25. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
26. Fais, S., M. R. Capobianchi, I. Abbate, C. Catilletti, M. Gentile, P. C. Fei, F. Ameglio, and F. Dianzani. 1995. Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules (ICAM-1) and HIV-1 viral matrix protein. AIDS 9:329-335.
27. Feng, Y., C. C. Broder, P. E. Kennedey, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
28. Fenyö, E. M., L. Morfeldt-Manson, F. Chiodi, and B. Lind. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
29. Folks, T., J. Kelly, S. Benn, A. Kinter, J. Justement, J. Gold, R. Redfield, K. W. Sell, and A. S. Fauci. 1986. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J. Immunol. 136:4049-4053.
30. Fortin, J.-F., R. Cantin, G. Lamontagne, and M. Tremblay. 1997. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:3588-3596.
31. Fortin, J.-F., R. Cantin, and M. Tremblay. 1998. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J. Virol. 72:2105-2112.
32. Frank, I., H. Stoiber, S. Godar, H. Stockinger, F. Steindl, H. W. D. Katinger, and M. P. Dierich. 1996. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS 10:1611-1620.
33. Gelderblom, H., H. Reupke, T. Winkel, R. Kunze, and G. Pauli. 1987. MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses. Z. Naturforsch. 42:1328-1334.
34. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferrua, R. Mitra, T. Phipps, L. A. Wahl, H. C. Lane, A. S. Fauci, D. S. Burke, D. Skillman, and M. S. Meltzer. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1428-1441.
35. Gluschankof, P., I. Mondor, H. S. Gelderblom, and Q. J. Sattentau. 1997. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 230:125-133.
36. Gomez, M. B., and J. E. K. Hildreth. 1995. Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1. J. Virol. 69:4628-4632.
37. Hedman, H., and E. Lundgren. 1992. Regulation of LFA-1 activity in human B cells. J. Immunol. 149:2295-2299.
38. Henderson, L. E., R. Sowder, T. D. Copeland, S. Oroszlan, L. O. Arthur, W. G. Robey, and P. J. Fischinger. 1987. Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Virol. 61:629-632.
39. Hockley, D. J., R. D. Wood, J. P. Jacobs, and A. J. Garrett. 1988. Electron microscopy of human immunodeficiency virus. J. Gen. Virol. 69:2455-2469.
40. Hoxie, J., T. P. Fitzharris, P. R. Yougbar, D. M. Matthews, J. L. Rackowski, and S. F. Radka. 1987. Nonrandom association of cellular antigens with HTLV-III virions. Hum. Immunol. 18:39-52.
41. Kanner, S. B., L. S. Grosmaire, J. A. Ledbetter, and N. K. Damle. 1993. β2-Integrin LFA-1 signaling through phospholipase C-γ1 activation. Proc. Natl. Acad. Sci. USA 90:7099-7103.
42. Keizer, G. D., W. Visser, M. Vliem, and C. C. Figdor. 1988. A monoclonal antibody (NKI-L16) directed against a unique epitope on the α-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J. Immunol. 140:1393-1400.
43. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767-768.
44. Lasky, L., G. Nakamura, D. H. Smith, C. Fernie, C. Shimasaki, E. Patzer, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
45. + T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69:3712-3720.
46. Maréchal, V., F. Clavel, J.-M. Heard, and O. Schwartz. 1998. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72:2208-2212.
47. Merloo, T., M. A. Sheikh, A. C. Bloem, A. de Ronde, M. Schutten, C. A. C. van Els, P. J. M. Roholl, P. Joling, J. Goudsmit, and H.-J. Schuurman. 1993. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. J. Gen. Virol. 74:129-135.
48. Merloo, T. H., H. K. Parmentier, A. D. M. E. Osterhaus, J. Goudsmit, and H.-J. Schuurman. 1992. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. AIDS 6:1105-1116.
49. Orentas, R. J., and J. E. K. Hildreth. 1993. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses 9:1157-1165.
50. Pantaleo, G., C. Graziosi, L. Butini, P. A. Pizzo, S. M. Schnittman, D. P. Kotler, and A. S. Fauci. 1991. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88:9838-9842.
51. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-335.
52. Parrot, D. M., and P. C. Wilkinson. 1981. Lymphocyte locomotion and migration. Prog. Allergy 28:193-284.
53. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8932-8936.
54. Posner, M. R., C. A. Cavacini, C. L. Emes, J. Power, and R. Bym. 1993. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquired Immune Defic. Syndr. 6:7-14.
55. Rizzuto, C. D., and J. G. Sodroski. 1997. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J. Virol. 71:4847-4851.
56. Rothlein, R., M. L. Dustin, S. D. Marlin, and T. A. Springer. 1986. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137:1270-1274.
57. Rouse, R. V., J. A. Ledbetter, and I. L. Weissman. 1982. Mouse lymph node germinal centers contain a selected subset of T cells - the helper phenotype. J. Immunol. 128:2243-2246.
58. Saarloos, M.-N., B. L. Sullivan, M. A. Czerniewski, K. D. Parameswar, and G. T. Spear. 1997. Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1. J. Virol. 71:1640-1643.
59. Saifuddin, M., C. J. Parker, M. E. Peeples, M. K. Gorny, S. Zolla-Pazner, M. Ghassemi, I. A. Rooney, J. P. Atkinson, and G. T. Spear. 1995. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J. Exp. Med. 182:501-509.
60. Sanders, M. E., M. W. Makgoba, S. O. Sharrow, D. Stephany, T. A. Springer, H. A. Young, and S. Shaw. 1988. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J. Immunol. 140:1401-1407.
61. Sattentau, Q. J. 1992. CD4 activation of HIV fusion. Int. J. Cell Cloning 10:323-332.
62. Schols, D., R. Pauwels, J. Desmyter, and E. De Clerk. 1992. Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology 189:374-376.
63. Staunton, D. E., S. D. Marlin, C. Stratowa, M. L. Dustin, and T. Springer. 1988. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin families. Cell 52:925-933.
64. Tremblay, M. J., J.-F. Fortin, and R. Cantin. 1998. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today 19:346-351.
65. Trowbridge, I. A., and M. L. Thomas. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116.
66. van de Stolpe, A., E. Caldenhoven, B. G. Stade, L. Koenderman, J. A. M. Raaijmakers, J. P. Johnson, and P. T. van der Saag. 1994. 12-O-Tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J. Biol. Chem. 269:6185-6192.
67. Woska, J. R. J., M. M. Morelock, D. D. Jeanfavre, and B.-J. Bormann. 1996. Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function-associated antigen-1. J. Immunol. 158: 4680-4685.
68. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
69. Zack, J. A., A. J. Cann, J. P. Lugo, and I. S. Y. Chen. 1988. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 240:1026-1029.
70. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717-1725.